Table 1

Cancer research investment awards and funding by site. All investment reported in 2013 UK pounds

All funders where investment data were availableCancer Research UK
Site of cancerNumber of awardsPercentage of totalSum investment (£)Percentage of totalMean award, £ (SD)Median award, £ (IQR)Number of awardsPercentage of all oncology research awards
Breast57113.3%£137 960 1075.8%241 611 (414 584)135 752 (25 000–216 673)2738.3%
Haematological115826.9%£381 008 39416.0%329 022 (476 943)186 813 (120 437–272 324)2256.9%
Colorectal1473.4%£77 279 8573.2%525 713 (674 881)251 800 (102 078–819 866)2056.2%
Prostate922.1%£135 290 7795.7%1 470 552 (6 156 372)333 757 (155 227–721 037)1233.7%
Ovarian481.1%£44 709 9381.9%931 457 (3 380 145)226 764 (131 990–627 401)1123.4%
Lung821.9%£24 263 2801.0%295 893 (556 278)146 123 (66 701–242 934)892.7%
Skin872.0%£22 179 0110.9%254 931 (453 726)85 406 (69 629–248 603)842.6%
Brain220.5%£9 994 2550.4%454 284 (498 933)401 046 (196 928–528 008)832.5%
Upper GI180.4%£19 094 2300.8%1 060 791 (1 448 010)788 850 (80 964–1 296 962)802.4%
Head and neck200.5%£18 250 6320.8%912 531 (1 003 091)389 751 (167 358–1 602 465)682.1%
Renal190.4%£13 885 4960.6%730 815 (678 732)479 197 (244 075–1 252 574)481.5%
Bladder100.2%£1 173 8560.0%117 385 (106 902)94 520 (29 264–173 855)481.5%
Cervical260.6%£14 328 4020.6%551 092 (877 250)210 179 (88 934–368 402)431.3%
Pancreatic160.4%£9 453 5770.4%590 848 (519 850)276 237 (191 804–1 033 948)401.2%
Bone130.3%£17 242 1830.7%1 326 322 (1 604 685)685 853 (243 559–1 999 907)290.9%
Liver370.9%£25 037 5411.0%676 690 (847 151)319 082 (177 974–776 480)200.6%
Mesothelioma300.7%£4 476 0880.2%149 202 (101 201)137 103 (95 895–205 500)110.3%
Cholangiocarcinoma20.0%£582 4050.0%n/an/a110.3%
Testicular140.3%£5 949 9900.2%424 999 (507 277)242 175 (102 938–411 010)110.3%
Thyroid40.1%£1 375 8810.1%n/an/a70.2%
Total4299£2 388 152 318555 513 (1 429 510)231 559 (114 619–487 063)3284
  • GI, gastrointestinal; n/a, not applicable.